Home › Funds › GHE, LLC › ABT

GHE, LLC position in ABT

ABBOTT LABORATORIES · Health Care

GHE, LLC reported holding 12,577 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$1.1M, representing 0.44% of its reported portfolio and ranking #35 among its reported holdings. GHE, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)12.58K sh
Reported value held$1.14M
Portfolio Weight0.44%
First reportedQ3 2023
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How GHE, LLC's ABT position evolved

GHE, LLC first disclosed a stake in ABT in Q3 2023 at 12,365 shares (US$1.2M). The position peaked in Q1 2025 at 15,026 shares, worth US$2.0M. Across 12 filings, GHE, LLC increased the stake 5 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q2 2026) shows 12,577 shares valued at US$1.1M — an increase of 263 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 12.37K $1.20M New
Q4 2023 12.55K $1.38M Add
Q1 2024 12.60K $1.43M Hold
Q2 2024 12.60K $1.31M Hold
Q3 2024 14.47K $1.65M Add
Q4 2024 15.19K $1.72M Add
Q1 2025 15.03K $1.99M Reduce
Q2 2025 12.86K $1.75M Reduce
Q3 2025 12.82K $1.72M Hold
Q4 2025 13.43K $1.68M Add
Q1 2026 12.31K $1.26M Reduce
Q2 2026 12.58K $1.14M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has GHE, LLC held ABT?

GHE, LLC has disclosed ABT holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is GHE, LLC's current position in ABT?

As of Q2 2026, GHE, LLC holds 12.58K shares of ABT (ABBOTT LABORATORIES), valued at $1.14M, representing 0.44% of its reported portfolio and ranking #35.

Has GHE, LLC been buying or selling ABT?

In the latest 13F filing (Q2 2026), GHE, LLC increased its position in ABT. The position peaked in Q1 2025 at 15.03K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.